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Abstract: The need for sensitive imaging techniques to detect tumor cells is an important 
issue in cancer diagnosis and therapy. Surface-enhanced Raman scattering (SERS), realized by 
chemisorption of compounds suitable for Raman spectroscopy onto gold nanoparticles, is a new 
method for detecting a tumor. As a proof of concept, we studied the use of biocompatible gold 
nanostars as sensitive SERS contrast agents targeting an ovarian cancer cell line (SKOV3). Due 
to a high intracellular uptake of gold nanostars after 6 hours of exposure, they could be detected 
and located with SERS. Using these nanostars for passive targeting after systemic injection in a 
xenograft mouse model, a detectable signal was measured in the tumor and liver in vivo. These 
signals were confirmed by ex vivo SERS measurements and darkfield microscopy. In this study, 
we established SERS nanostars as a highly sensitive contrast agent for tumor detection, which 
opens the potential for their use as a theranostic agent against cancer.
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Introduction
Diagnosing cancer at an early stage by improved imaging approaches may contribute 
to increased survival of cancer patients. Optical imaging techniques such as surface-
enhanced Raman scattering (SERS) have become more popular in this field where the 
optical selectivity is used for better tumor-tissue discrimination. SERS exploits the 
enhanced Raman scattering by bringing a Raman-active molecule close to a metal surface 
such as on gold nanoparticles. Owing to this, an enhancement by 1010–12 of the Raman 
signal compared to unlabeled nanoparticles could be realized.1 As a consequence, SERS 
has made its way into the biomedical field since the technique enables a very sensitive 
detection of molecules and easy discrimination based on a fingerprint spectrum.
On the one hand, SERS has been introduced for the detection of analytes in a 
label-free manner where they interact with the metal surface, while on the other hand, 
SERS-active nanostructures, where Raman-active molecular labels are already coupled 
to the surface, are used as “SERS labels”, similar to fluorescent labels. SERS offers 
several advantages compared with conventional fluorescent labels due to their structure 
sensitivity and absence of photodecomposition.2,3 Examples for the successful use of 
the Raman labeling approach are the discrimination of different cell types, viruses, 
and other lab-on-a-chip applications.4–9 Also in vivo, these SERS-active structures, 
such as nanorods or nanospheres, have shown the potential to discriminate these labels 
inside different tissues.10,11
Gold nanoparticles have been extensively studied as potential SERS contrast agents 
for cancer diagnosis.7,10–16 The SERS imaging technique depends on the enhance-
ment factor of the nanoparticle’s Raman signal by creating local high electric fields. 
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For enhancing the Raman signal, several shapes have been 
introduced, ranging from nanorods, nanostars, dimers, and 
others.11 All these nanoparticles are equipped with sharp 
tips that generate high electric fields upon irradiation.17 
In particular, nanostars have several sharp tips, which make 
them efficient surfaces/carriers of SERS labels and enables 
detection down to pM concentrations.18,19 In vitro applica-
tions of sensitive SERS imaging using nanostars have been 
demonstrated for the study of cellular pathways, intracellular 
pH sensing, or the detection of specific cells in histology 
sections.20–22 Despite their high sensitivity, the use of nano-
stars as SERS contrast agents has not been pursued in vivo, 
to the best of our knowledge.
In this study, we intend to use the high sensitivity of these 
nanostars, compared with other nanoparticle shapes, as an 
in vivo diagnostic agent for the detection of cancer cells. For this, 
the nanostars have to be decorated with SERS reporters. This 
is not as straight forward as it sounds, as changing the coating 
of the nanostars may affect their stability under physiological 
conditions. Using in vitro experiments, we evaluated the prop-
erties and the potential of SERS-labeled nanostars to passively 
target tumor cells. By an in vivo passive targeting strategy, 
SERS was used to evaluate accumulation of nanostars in the 
tumor by the enhanced permeability and retention effect.23,24
Materials and methods
Nanostars synthesis and functionalization
Gold nanostars were prepared based on the procedure 
described by Hao et al25 and further optimized according 
to Van de Broek et al.26 In brief, 2 mg bis(sulfonatophenyl) 
phenylphosphine dihydrate dipotassium (Strem Chemicals, 
Newburyport, MA, USA) and 100 μL H
2
O
2 
(30% v/v, 
Air Products, Vilvoorde, Belgium) were added to 50 mL 
6.8 mM aqueous sodium citrate solution (Acros Organics, 
Geel, Belgium). Next, 100 μL of 0.075 M HAuCl
4
 (Acros 
Organics) was added slowly under constant stirring at 
room temperature. Compared with previously published 
articles, by using an Atlas Syringe Pump (Syrris, Ruisbroek, 
Belgium), a slower addition rate of 12.5 μL/min was used 
in order to achieve the desired shape and size.25 The 50 mL 
gold nanostar suspension was centrifuged at 4,500 rpm for 
1 hour, and the pellet was resuspended in 10 mL of water. 
For functionalizing the nanostars with a Raman-active label, 
100 μL NaOH (0.5 M) and 1 mL of the desired DTNB 
concentration was added to the nanostar suspension. After 
1.5 hours of shaking, the nanostar suspension was centrifuged 
for 60 minutes at 4,500 rpm, the supernatant was discarded, 
and the nanostar pellet resuspended in water. Then, the 
nanostars were functionalized with self-assembled monolayer 
(SAM) (HS–(CH
2
)11–(O–CH
2
–CH
2
)
6
–O–CH
2
–C
4
H
3
NO
2
)
2
 
according to the same protocol as used for the DTNB label. 
After functionalization, these nanostars were characterized 
using ultraviolet–visible absorption spectroscopy (Shimadzu 
UV-1601PC, Brussels, Belgium), dynamic light scattering 
(Zetasizer Nano ZS90 DLS, Malvern Nanosizer, Malvern, 
UK), and transmission electron microscopy (TEM; Tecnai 
F30, FEI Company, Eindhoven, the Netherlands).
To evaluate their SERS imaging capabilities, the nanos-
tars were either dried on a silicon wafer overnight or loaded 
into an agar phantom.27 These nanostars were visualized 
using Raman microscopy (type alpha 300R, WITec, Ulm, 
Germany; [785 nm, 40 mW, 5 seconds integration time, 
raster of 40×40 μm]).
cell culture
SKOV3 cells (ATCC® HTB77, Cedex, France) were cul-
tured in medium (Roswell Park Memorial Institute) 1640 
medium supplemented with 10% fetal calf serum, 50 units/L 
penicillin, 50 μg/mL streptomycin, and 2 mM l-glutamine. 
Cells were incubated at 37°C in 5% CO
2
 environment. 
All cell culture reagents were obtained from Thermo Fisher 
Scientific (Waltham, MA, USA). The SKOV3 cells were 
transduced with a lentiviral vector (LV-CMV-eGFP-T2A-
fLuc) to stably express eGFP and firefly luciferase.28
Darkfield and Raman microscopy of 
cell–nanostar interaction
Tumor cells (SKOV3) were seeded with 150,000 nanos-
tars per well in a 12-well plate to study the cell–nanostar 
interaction. After 24 hours, nanostars with different SAMs 
(2.3×1010 particles in 1 mL) were added to the cells and 
incubated for 3 hours, 6 hours, and 24 hours. After washing 
with phosphate-buffered saline (PBS), these cells were again 
incubated overnight with fresh medium. After trypsinization, 
300 μL of the cell suspension was either acid digested for 
inductively coupled plasmon – optical emission spectrometry 
(ICP-OES) or plated on a coverslip in 1 mL of fresh medium 
in a 12-well plate and incubated overnight. After fixation 
with 4% paraformaldehyde in PBS, these coverslips were 
mounted on a glass slide and visualized by darkfield micros-
copy (Olympus BX51 equipped with a U-DCW condenser; 
Olympus, Berchem, Belgium) or Raman microscopy (type 
alpha 300R, WITec; 785 nm, 40 mW, 5 seconds integration 
time, raster of 40×40 μm).
evaluation of in vivo biodistribution
Female Hsd:Athymic Nude-Foxn1nu mice were used (8 weeks; 
Harlan, Horst, the Netherlands) for these experiments. 
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All animal experiments were approved by the local animal 
ethics committee of the KU Leuven and were performed 
according to the national and European regulations. The 
animals were kept in individually ventilated cages with food 
and water ad libitum. During all imaging experiments, tumor 
cells and nanostar injections, the animals were anesthetized 
with 1.5% isoflurane in 100% O
2
. The body temperature 
and respiration rate were monitored and maintained at 37°C 
and 80–120 minute-1, respectively. A total of 1×107 SKOV3 
tumor cells suspended in 100 μL were injected into each 
hind limb of the mice and left for 2 weeks to grow into solid 
tumors.29 These tumors (size .150 μm3) were validated using 
magnetic resonance imaging (MRI) and bioluminescence 
imaging (BLI).
MRI data acquisition and processing were similar to 
previous reports.30 In brief, in vivo MRI was performed 
using a 9.4 T small animal MRI system (BioSpec, Bruker 
Biospin, Ettlingen, Germany) equipped with a gradient 
insert and a maximum gradient strength of 600 mT/m. A 
quadrature transmit–receive coil (Bruker Biospin) with an 
inner diameter of 7 cm was used for data acquisition. The 
MRI protocol included a spin echo sequence with repeti-
tion time =6,000 ms, echo time =15.8 ms, matrix =200×200 
mm, field of view 40×40 mm, slice thickness =0.5 μm and 
40 slices.
BLI experiments were performed with an IVIS 100 
imaging system (PerkinElmer Inc., Waltham, MA, USA). 
The mice were injected intravenously (iv) with D-luciferin 
(126 mg/kg body weight, Promega Corporation, Fitchburg, 
WI, USA) dissolved in PBS (15 mg/kg). Afterward, they 
were placed in the IVIS 100 imaging system, and one image 
frame per second was acquired until a signal intensity 
plateau was reached. The following settings were used: 
1 second exposure time, field of view of 10 cm, binning 
of 4, and an frame per stop of 8. For in vivo quantification 
of fLuc reporter gene activity, the data were analyzed as 
photon flux per second (p/s) from an 1 cm2 circular region 
of interest located on the tumor using the Living Image 
software (version 2.50.1, PerkinElmer Inc.). The signal 
intensity values at different time points (day 0, 1, 5, 8, 
and 15) were presented relative to the BLI signal of the 
same mouse at day 0.
After formation of tumors, nanostars (200 μL, 2.3 mg 
Au/mL) were injected via the tail vein (n=3). After 3 hours, 
the mice were imaged with Raman microscopy (785 nm, 
40 mW, 60 seconds integration time, raster of 40×40 μm) at 
specific locations: tumor, liver, and skin tissue. Subsequently, 
the animals were sacrificed and transcardially perfused with 
4% paraformaldehyde. The liver, spleen, kidneys, and tumors 
were dissected and stored in PBS with 0.1% sodium azide 
(Sigma-Aldrich Co., St Louis, MO, USA). These organs 
and tumors were visualized ex vivo using the Raman Witeq 
microscope with the same settings as for the in vivo experi-
ments. For darkfield microscopy, the dissected organs were 
embedded in paraffin to make sections of 7 μm thickness with 
a microtome (HM360, Prosan, Merelbeke, Belgium). The 
sections were placed on microscope slides and deparaffinized 
before darkfield microscopy.
Results
Nanostar synthesis and functionalization
Nanostars are synthesized so that they absorb light in the 
near-infrared region approximately 665±9.7 nm with an 
average hydrodynamic diameter of 66.3±7.8 nm. TEM shows 
the anisotropic shape of the nanostars (Figure S1). The syn-
thesis and characterization by ultraviolet–visible absorption 
spectroscopy, dynamic light scattering, and TEM have been 
described previously.31,32 DTNB was chosen as a SERS label 
as it has a high Raman cross-section, high reactivity to gold 
surfaces, and has been used previously.33–37 To find the opti-
mal DTNB concentration for functionalizing the nanostars 
with this label, a range of concentrations (10 mM, 1 mM, 
0.1 mM, 0.01 mM, and 0.001 mM) was tested on these nano-
stars. An optimal concentration of 0.1 mM was chosen since 
it did not affect the stability of the nanostars. A broadening 
and decrease of intensity of the localized surface plasmon 
resonance (LSPR) band occurred at higher concentrations, 
indicating instability of the nanostars (Figure S2). This insta-
bility was confirmed by a very large hydrodynamic diameter 
increase of 21.04±0.84 nm when functionalizing the nano-
stars with 10 mM DTNB (Table S1). Moreover, starting at 
a functionalization concentration of 0.1 mM, a second band 
appeared in the absorption spectrum at ~412 nm due to the 
creation of 3-thio-6-nitrobenzoate (TNB-) molecules in the 
solution. The successful functionalization of these nanostars 
with the DTNB molecule was confirmed by a red shift of the 
absorption band due to a change in the refractive index38 and 
increase in the hydrodynamic diameter by 8.14±0.63 nm. 
With only the DTNB label on the nanostar surface, the nano-
stars are only stable in salt concentrations up to 0.03 M NaCl, 
losing the blue suspension color at higher salt concentrations 
(Figure S3).
For increasing the stability under physiological conditions, 
the nanostars were functionalized afterward with SAM. As 
for the DTNB functionalization, a red shift in the LSPR band 
(5.30±1.66 nm) and an increase in the hydrodynamic diameter 
(6.12±1.57 nm) were measured after SAM functionalization 
(Figure 1). Nanostars functionalized with a SAM molecule are 
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stable up to a concentration of 1 M NaCl, maintaining their 
blue color (Figures 1 and S3). After functionalization, the 
nanostars had an anionic zeta potential of -33.3±3.4 mV.
Due to functionalization with SAM molecules, Raman 
labels on the nanostars could be replaced. Therefore, the 
SERS contrast generation (parameters: 785 nm, 40 mW, 
and 10 seconds integration time) was measured using dried 
nanostars on a silicon wafer, either from nanostars functional-
ized with DTNB and SAM or nanostars only functionalized 
with SAM. As shown in Figure 2, a DTNB Raman spectrum 
free of contaminating signals could be recorded from the 
nanostars functionalized with DTNB and SAM, with the 
highest intensity at 1,333 cm-1, resulting in an spectrum 
that was identical to what had previously been described in 
the literature.33,34,39,40 This confirms that the SAM molecules 
did not replace all the DTNB molecules on the nanostars. 
As expected for the nanostars–SAM, no SERS signal could 
be measured.
To evaluate the SERS capabilities of nanostars for later 
in vivo applications, the sensitivity of SERS detection for 
the different nanostar concentrations (250 μM, 125 μM, 
62.5 μM, 31.3 μM, 15.7 μM Au) was evaluated after loading 
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Figure 1 characterization of the gold nanostars using UV-Vis absorption spectroscopy.
Notes: (A) UV–Vis spectrum of the nonfunctionalized nanostars, nanostars functionalized with 0.1 mM DTNB and saM. Inset shows the lsPr band shift to the NIr region 
due to the binding of these molecules to the nanostar surface. (B) lsPr band of the nanostars functionalized with DTNB and saM for different salt concentrations showing 
no instability.
Abbreviations: UV–Vis, ultraviolet–visible; lsPr, localized surface plasmon resonance; saM, self-assembled monolayer; DTNB, 5,5-dithio-bis-(2-nitrobenzoic acid); NIr, 
near-infrared region.
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Figure 2 sers characterization of dried gold nanostars on a silicon wafer.
Notes: (A) Brightfield microscopy images of the nanostars dried on a silicon wafer where the SERS signal intensity at 1,333 cm-1 is visualized in the zoomed-in picture. 
(B) SERS spectrum of the corresponding nanostars either labeled with DTNB and SAM or only functionalized with the SAM molecule. The magnification for the images is 
100 micrometers.
Abbreviations: DTNB, 5,5-dithio-bis-(2-nitrobenzoic acid); sers, surface-enhanced raman scattering.
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them into an agar phantom. During SERS imaging, they 
were irradiated with a continuous laser (785 nm, 40 mW, 
and 60 seconds integration time). A detectable DTNB spec-
trum was measured with the maximum intensity at 1,333 cm-1 
for all nanostar concentrations of the phantom (Figure 3). 
When plotting the intensity at 1,333 cm-1 for the different 
gold concentrations, a linear relation was deducted between 
the Raman intensity and gold concentration. Using a linear 
fit, a limit of detection (LOD) of 13 μM was calculated.
sers to visualize the nanoparticle uptake 
in cultured tumor cells
Prior to using these nanostars in vivo, the in vitro uptake 
by SKOV3 tumor cells was studied. After 3 hours, 6 hours, 
and 24 hours of incubation, the increase in the intracellular 
amount of nanostars was visualized by darkfield microscopy 
and quantified by ICP-OES. The gold quantity increased 
over time, going from 1.3±0.9 pg Au/cell after 3 hours to 
4.4±0.68 pg Au/cell after 6 hours and to 8.05±1.1 pg Au/cell 
measured after 24 hours, compared with 0.1±0.05 pg 
Au/cell for the cells without nanostar labeling using ICP-
OES. Darkfield microscopy confirmed the intracellular 
uptake of nanostars (Figure 4) the TEM images also con-
firms the intracellular uptake of the nanostars in the cells 
(Figure S4).
On these time points, we also acquired the SERS spectra 
of the cultured cells by raster scanning with a resolution of 
1 μm. Under these conditions, the Raman spectra are domi-
nated by the SERS signal of the nanostars. When acquiring 
the SERS spectra of the cells labeled for 6 hours and 24 hours 
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Figure 3 sers sensitivity study.
Notes: (A) sers spectrum for different concentrations of the sers labeled nanostars embedded in an agar phantom. (B) The intensity of the signal at 1,333 cm-1 plotted 
for the different concentrations.
Abbreviation: sers, surface-enhanced raman scattering.
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Figure 4 Intracellular study of the nanostars using darkfield microscopy and SERS.
Notes: (A) Darkfield microscopy pictures where an increase of gold nanostars (yellow) inside the tumor cells (green) is visualized over time. (B) sers spectrum of the 
corresponding cells labeled with nanostars, showing the highest intensity peak at 1,333 cm-1 (black arrow).
Abbreviation: sers, surface-enhanced raman scattering.
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with nanostars, a clear SERS signal was measured (Figure 4). 
A distinct peak at 1,333 cm-1 was detected, which was absent 
for the spectrum of unlabeled control cells. The strongest 
SERS response was observed after 24 hours of labeling. 
Together with the higher Au concentration measured after 
24 hours of incubation, this indicates that the SERS label did 
not detach or exocytose from the nanostars after intracellular 
uptake. After 3 hours, no distinct Raman peak was seen 
despite the presence of a small number of nanostars inside the 
tumor cells, as indicated by darkfield microscopy. Moreover, 
under all conditions, a significant background signal was 
observed between 1,300 cm-1 and 1,400 cm-1, which could 
be attributed to the glass coverslip. Using quartz coverslips 
reduced the background signal, thus potentially increasing 
the sensitivity of in vitro detection. As the Raman mapping 
indicates, the SERS signals originate from specific locations 
inside the cells (Figure 5).
sers as an in vivo imaging tool using gold 
nanostars as contrast agents
To validate the in vivo SERS imaging capabilities of gold 
nanostars as a diagnostic agent, the functionalized nanostars 
were iv injected in mice bearing a SKOV3 xenograft tumor. 
The animals had a tumor measuring .150 cm3, validated by 
MRI or a BLI intensity .1010 photon flux (p/s) (Figure S5). 
These nanostars passively accumulate inside the tumor 
interstitium through the well-described enhanced perme-
ability and retention effect.41 No immediate adverse effect 
on the animal’s health or animal deaths occurred due to the 
particle injections. Concentrations used in this study were 
also lower than concentrations published before for in vivo 
experiments and considered to be safe.42,43 Three hours after 
iv injection of these nanostars, SERS spectra of the tumor, 
liver, and skin tissue were recorded with the Raman micro-
scope (Figure S2). Both, the SERS spectra of the liver and 
tumor are shown in Figure 6 after background and skin tissue 
deduction. A clear SERS band at 1,333 cm-1 was visualized 
for both tissue types, indicating accumulation of the nanostars 
in the respective organs. Due to recognition of the nanostars 
by the reticuloendothelial system, the highest SERS signal 
intensity was observed in the liver, with an intense peak at 
1,333 cm-1. Next to the liver, nanostars also accumulated 
in the tumor with a corresponding DTNB SERS spectrum. 
However, due to the inhomogeneous accumulation of the 
nanostars inside the tumor, the SERS spectrum could not be 
detected at all locations within the tumor.
After sacrificing the animals, several excised organs 
were examined to evaluate their nanostar accumulation and 
corresponding SERS signal ex vivo (Figure 7). By using 
ex vivo SERS imaging of the organs, clear DTNB spectra 
were observed for the liver, spleen, and tumor border, con-
firming the in vivo SERS experiments (Figure 7). No DTNB 
SERS signals were detected in the kidneys and the center of 
the tumor, corresponding to the background SERS spectrum 
that was acquired. Concerning the tumor tissue, the nanostars 
seemed to preferentially accumulate in its periphery, most 
likely due to a higher vascular density. These results were 
confirmed by darkfield images, where nanostars were visual-
ized inside the corresponding tissues.
Figure 5 Brightfield image of a tumor cell overlaid with a surface-enhanced Raman 
scattering intensity image where high intensity signals with a wavenumber of 
1,333 cm-1 are visualized in yellow color (cutoff value signal intensity: 4,500 au).
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Figure 6 surface-enhanced raman scattering spectrum of the liver and tumor 
3 hours after intravenous injection of nanostars.
Notes: signal from the background and control tissue has been subtracted. For 
both tissue types, a clear peak at 1,333 cm-1 was visible.
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Figure 7 ex vivo analysis of the nanostar accumulation in different tissues.
Notes: (A) Darkfield images of the different tissues where nanostars (gold spots) were clearly visualized inside the liver, spleen and in lesser concentration at the tumor 
border. (B) surface-enhanced raman scattering spectra of the different tissues where a DTNB spectrum was observed for the spleen, liver, and tumor border.
Abbreviation: DTNB, 5,5-dithio-bis-(2-nitrobenzoic acid).
Discussion
Due to its unique fingerprint on Raman spectroscopy, SERS 
has recently emerged as one of the most promising tools 
for in vivo biosensing and imaging. By changing the shape 
of nanoparticles, different types of SERS-labeled gold 
structures have been introduced and described.13,44,45 Due to 
their multiple sharp branches, generating high local electric 
fields, nanostars have shown a superior SERS enhance-
ment factor compared with nanospheres and nanorods.46 
This superior enhancement factor is due to a higher surface 
area compared with other nanoparticles, inducing a higher 
loading of the Raman-active molecules on the surface. In 
addition, for polarization, the nanoparticle surface should 
have an orthogonal orientation compared with the incom-
ing wavelength to benefit from maximum light absorption. 
Since the nanostars have several tips, there will always one 
orthognal compared to the incoming wave length. That is the 
advantage compared to nanorods. However, the focus for in 
vivo applications has been mainly on the use of nanorods.11,47 
To the best of our knowledge, the use of gold nanostars 
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as an in vivo diagnostic agent for cancer has never been 
addressed before. In this article, we prove the applicability 
of these nanostars as an in vivo diagnostic agent for tumors 
using SERS. By using SERS, the interaction of the nanostars 
with the cells could be visualized in vitro as well measured 
in vivo on tissue level.
To maximize the potential op SERS imaging using 
nanostars, the functionalization conditions of the nanostars 
with the Raman label had to be examined. An important 
criterion is the maximum DTNB concentration of 0.1 mM, 
we have proven that the maximum DTNB concentration to 
add is 0.1 mM since at higher concentrations the nanostars 
are unstable.48 Nanostars covered with DTNB, resulted in 
negatively charged TNB- in solution. These negative moi-
eties induce osmotic depletion in the suspension, inducing 
instability of the nanostars. The presence of TNB− molecules 
is confirmed by an absorbance band at ~412 nm, which was 
measured starting from a concentration of 0.1 mM. However, 
a negative molecule is more optimal for functionalization as 
the synthesized nanostars are capped with negative citrate 
molecules. It is generally known that citrate-capped nano-
particles, as our nanostars after synthesis, are unstable when 
they are functionalized with a neutral or positively charged 
molecule without any polyethylene glycol units.31 In other 
words, adding positively charged molecules will change 
the zeta potential from negative to positive, thus inducing 
nanoparticle aggregation, which is notified by a decrease in 
the intensity of the LSPR band. An extra SAM functionaliza-
tion step made the nanostars applicable for SERS detection 
under physiological conditions, overcoming these stability 
problems. As this decrease is not visible at the same salt 
concentration for the DTNB SAM functionalized nanostars, 
we could conclude that these nanostars are stable.
A crucial parameter for having high sensitivity using 
contract agents as nanoparticles in imaging is the LOD of 
these nanostars in phantoms. We measured an LOD of 13 μM, 
which is higher compared to previously reported LODs.18,49–50 
There are several potential reasons for this higher concentra-
tion. We embedded the nanostars under an agar layer of 2 mm 
thickness to better mimic in vivo conditions, which decreases 
the irradiation effectiveness. Another reason is the mismatch 
between the laser wavelength and the plasmon absorption 
band (785 nm vs 680 nm). In this way, the LSPR effect 
generated at the tips is not that strong, resulting in a smaller 
enhancement of the DTNB Raman signal. The sensitivity 
could be increased by incorporating the SERS label directly 
into the SAM molecule, covering the complete nanoparticle 
with this Raman-active label.34 Another strategy is to have 
built-in hot spots in the particle itself, which can increase the 
SERS signal by 10.3,4,44,51,52
In spite of the LOD we measured, the nanostars could be 
easily visualized by using SERS, as confirmed by ICP-OES, 
TEM, and darkfield microscopy. These nanostars are taken 
up by the cells, as mentioned by the protocol used by Trekker 
et al27 and the TEM images. We established that a minimum 
concentration of 4.4 pg Au/cell is necessary to visualize the 
nanostars inside the cells. This concentration value corre-
sponds to the intracellular gold concentration, we have used 
the same protocol as in those papers where they have con-
cluded that with this protocol you measure the intracellular 
nanoparticle concentration.27,32 At higher concentrations, a 
nonlinear relation was noticed between the gold concentra-
tion and the SERS signal intensity. While for ICP-OES, an 
increase of 82% gold per cell was measured between 6 hours 
and 24 hours, an even higher SERS signal intensity increase 
of 135% was measured. As the nanostar concentrations shows 
a linear relationship with the Raman signal in the phantom 
measurements, the non-linear relationship in vitro is likely 
due to the creation of hotspots by the nanostars.5 The nanos-
tars will aggregate inside the acidic endosomal structures of 
the cells, which most likely will create these hotspot. These 
spots are known to have a larger SERS enhancement signal 
as observed. At these concentrations, no cell morphology 
changes have been observed, indicating nontoxic effects of 
the nanostars.
Here, we demonstrate the use of nanostars as an in vivo 
diagnostic agent for cancer. The concentration of the 
nanostars was lower compared with other in vivo studies 
where no toxicity was notified.42,43 The anionic charge and 
relatively large size decreases the penetration of these nano-
stars deeper inside the tumor tissues. By functionalizing 
these nanostars with a biological ligand targeting an over 
expressed receptor on the tumor cells, their accumulation 
within a tumor could potentially increase, as seen before 
with nanobodies targeting the HER2 receptor on the SKOV3 
tumor cells.32
As SERS imaging is limited by a light penetration depth 
of only 1–2 cm, this imaging modality can be used for 
detection of tumors under the skin after iv injection by a 
raster scanning method.11,53,54 SERS can be combined with 
computed tomography or photoacoustic imaging in a multi-
modal imaging approach for animal models. By using these 
other techniques, a full body and three-dimensional image 
of the tumor with the nanoparticle signal could be provided, 
which is not possible with SERS alone. Still, further technical 
developments of SERS can result in two-dimensional 
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imaging tools with fast scanning times by using a Raman 
microscope. For theranostic purposes, these nanostars could 
be used as a therapeutic agent for either photothermal therapy 
by increasing the tumor temperature to a lethal level for the 
tumor cells or photodynamic therapy by creating singlet 
oxygen atoms, which are toxic for tumor cells.12,52,54–56 SERS 
may even be used as an intraoperative imaging tool guid-
ing surgical removal of the tumor benefiting from the high 
Raman contrast imaging capabilities.57 During surgery, the 
extent and boundaries of tumors could be determined, which 
is perfectly feasible with 1–2 cm light penetration limits of 
SERS imaging. As shown in our study, nanostars will accu-
mulate preferentially at the tumor periphery, delineating the 
border of the tumor during imaging.
Conclusion
In summary, physiologically stable SERS-labeled nanostars 
were produced that showed stable SERS signal in agar phan-
toms down to a concentration of 12 μM. These nanostars 
were taken up by tumor cells in vitro, with accumulation in 
endosomal structures. SERS imaging confirmed intracellular 
uptake, where a concentration as low as 4.4 pg Au/cell could 
be detected. Using these unique properties, SERS signal 
from the nanostars could be detected in the liver and tumor 
after iv injection in a tumor-bearing mouse model. The pres-
ence of the nanostars has been confirmed by ex vivo SERS 
measurements combined with darkfield imaging. Based on 
our in vivo results, we demonstrated that gold nanostars can 
be used as an agent for cancer diagnosis using SERS as a 
cost-efficient and rapid optical imaging technique, with a 
potential future application intraoperative imaging during 
surgical tumor removal in patients.
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Supplementary materials
Table S1 For a given set of DTNB concentrations, the lsPr band shift and hydrodynamic diameter increase are reported together 
with the maximum salt concentration at which the nanostars remain in suspension
DTNB (mM) LSPR peak 
shift (nm)
Hydrodynamic 
diameter increase (nm)
Maximum salt 
concentration (M)
0.001 1.33±0.58 6.35±1.77 0.06
0.01 2.33±0.59 9.39±1.49 0.06
0.1 3.67±1.15 8.14±0.63 0.03
1 4.33±1.53 7.04±0.61 0.03
10 4.67±1.53 21.04±0.84 0.03
Note: Bold text indicates the value that was chosen to functionalize the nanostars with. 
Abbreviations: DTNB, 5,5-dithio-bis-(2-nitrobenzoic acid); lsPr, localized surface plasmon resonance.
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Figure S2 Nanostar functionalization characterization using UV–Vis absorption spectroscopy.
Notes: (A) UV–Vis of the nanostars functionalized with a range of different concentrations of DTNB. a second band is appearing due to the formation of TNB-. (B) lsPr 
band of the nanostars functionalized with 0.1 mM DTNB for different salt concentrations, showing the nanostar instability by a decrease in intensity.
Abbreviations: DTNB, 5,5-dithio-bis-(2-nitrobenzoic acid); lsPr, localized surface plasmon resonance; TNB, 3-thio-6-nitrobenzoate; UV–Vis, ultraviolet–visible.
Figure S1 Transmission electron microscopy image of the nanostars.
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Figure S3 Picture of the nanostars saM DTNB (A) and nanostars DTNB (B) 
suspension in 1 M Nacl.
Abbreviations: saM, self-assembled monolayer; DTNB, 5,5-dithio-bis-(2-nitro-
benzoic acid). Figure S4 Transmission electron microscopy image showing the uptake of the 
nanostars within vesicular structures of the cell.
Figure S5 (A) picture of the tumor-bearing animals. (B) Magnetic resonance image of animals showing the two tumors, one in each limb. (C) In vivo bioluminescence image 
illustrated in a color-coded intensity map.
